A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-10-12) →
What happened
Kyung NAM Pharm updated the terms of a rights issue to existing shareholders to raise US$14.1M, about 48.9% of its market value.
For context, this raise equals about 48.9% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Rights issue |
|---|---|
| Raise amount | US$14.1M |
| vs. market value | 48.9% |
| Filed | 2026-09-18, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260918000349 → open original filing |
Versions of this filing
- 2026-05-21Original
- 2026-06-23Amendment 1
- 2026-09-07Amendment 2
- 2026-09-18Amendment 3 (this page)
- 2026-10-12Amendment 4
Source: DART. Information only, not investment advice.